| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000045 | Autophagosome assembly | Affects phenotype | PMID:36087924 |
| GO:0001510 | Rna methylation | Affects phenotype | PMID:31875672 |
| GO:0001545 | Primary ovarian follicle growth | Increases phenotype | PMID:25810477 |
| GO:0001547 | Antral ovarian follicle growth | Decreases phenotype | PMID:23077170; PMID:31884101 |
| GO:0001552 | Ovarian follicle atresia | Increases phenotype | PMID:38685446 |
| GO:0001556 | Oocyte maturation | Decreases phenotype | PMID:26545148 |
| GO:0001649 | Osteoblast differentiation | Increases phenotype | PMID:28921615 |
| GO:0001678 | Cellular glucose homeostasis | Decreases phenotype | PMID:36438553 |
| GO:0001825 | Blastocyst formation | Decreases phenotype | PMID:28042535; PMID:36535558 |
| GO:0001835 | Blastocyst hatching | Decreases phenotype | PMID:36535558 |
| GO:0001964 | Startle response | Increases phenotype | PMID:37886449 |
| GO:0002191 | Cap-dependent translational initiation | Affects phenotype | PMID:27992464 |
| GO:0003016 | Respiratory system process | Decreases phenotype | PMID:27852937 |
| GO:0004035 | Alkaline phosphatase activity | Affects phenotype | PMID:28921615 |
| GO:0004602 | Glutathione peroxidase activity | Decreases phenotype | PMID:23077170; PMID:24706461 |
| GO:0004784 | Superoxide dismutase activity | Affects phenotype | PMID:24706461; PMID:24836450; PMID:28988496; PMID:29259978 |
| GO:0006006 | Glucose metabolic process | Affects phenotype | PMID:22953781 |
| GO:0006071 | Glycerol metabolic process | Affects phenotype | PMID:32522588 |
| GO:0006089 | Lactate metabolic process | Affects phenotype | PMID:22017230; PMID:32522588 |
| GO:0006096 | Glycolytic process | Increases phenotype | PMID:32522588 |
| GO:0006304 | Dna modification | Increases phenotype | PMID:38563870 |
| GO:0006351 | Dna-templated transcription | Affects phenotype | PMID:22321834 |
| GO:0006520 | Amino acid metabolic process | Affects phenotype | PMID:22017230 |
| GO:0006580 | Ethanolamine metabolic process | Affects phenotype | PMID:22017230 |
| GO:0006600 | Creatine metabolic process | Affects phenotype | PMID:22017230 |
| GO:0006606 | Protein import into nucleus | Affects phenotype | PMID:26751383 |
| GO:0006631 | Fatty acid metabolic process | Affects phenotype | PMID:22017230 |
| GO:0006635 | Fatty acid beta-oxidation | Affects phenotype | PMID:32522588 |
| GO:0006641 | Triglyceride metabolic process | Affects phenotype | PMID:22017230; PMID:22953781; PMID:32916427 |
| GO:0006644 | Phospholipid metabolic process | Affects phenotype | PMID:22017230 |
| GO:0006693 | Prostaglandin metabolic process | Affects phenotype | PMID:34942354 |
| GO:0006739 | Nadp metabolic process | Affects phenotype | PMID:22017230 |
| GO:0006749 | Glutathione metabolic process | Affects phenotype | PMID:24836450; PMID:28988496; PMID:29259978; PMID:38048874; PMID:39360521 |
| GO:0006754 | Atp biosynthetic process | Decreases phenotype | PMID:24706461; PMID:25677926 |
| GO:0006882 | Cellular zinc ion homeostasis | Decreases phenotype | PMID:35841924 |
| GO:0006909 | Phagocytosis | Decreases phenotype | PMID:30398665 |
| GO:0006915 | Apoptotic process | Affects phenotype | PMID:12490136; PMID:20453712; PMID:24412242; PMID:24706461; PMID:24836450; PMID:26597031; PMID:28042535; PMID:29259978; PMID:30810372; PMID:36087924; PMID:39307383 |
| GO:0006919 | Activation of cysteine-type endopeptidase activity involved in apoptotic process | Increases phenotype | PMID:30476341 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:28988496 |
| GO:0007005 | Mitochondrion organization | Decreases phenotype | PMID:36087924; PMID:39307383 |
| GO:0007010 | Cytoskeleton organization | Affects phenotype | PMID:36087924 |
| GO:0007033 | Vacuole organization | Affects phenotype | PMID:36087924 |
| GO:0007137 | Meiotic metaphase ii | Affects phenotype | PMID:28042535 |
| GO:0007155 | Cell adhesion | Affects phenotype | PMID:22321834 |
| GO:0007204 | Positive regulation of cytosolic calcium ion concentration | Increases phenotype | PMID:36005737 |
| GO:0007568 | Aging | Increases phenotype | PMID:36174712 |
| GO:0007612 | Learning | Affects phenotype | PMID:24978879 |
| GO:0008152 | Metabolic process | Affects phenotype | PMID:38065500 |
| GO:0008203 | Cholesterol metabolic process | Affects phenotype | PMID:22953781 |
| GO:0008217 | Regulation of blood pressure | Affects phenotype | PMID:32916427 |
| GO:0008219 | Cell death | Increases phenotype | PMID:26985823; PMID:34863575 |
| GO:0008283 | Cell population proliferation | Affects phenotype | PMID:22205965; PMID:24412242; PMID:24706461; PMID:26597031; PMID:29259978; PMID:30858031; PMID:38563870 |
| GO:0008284 | Positive regulation of cell population proliferation | Affects phenotype | PMID:31351048; PMID:33159713; PMID:36314267 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:31228551; PMID:31771930; PMID:37364752 |
| GO:0008611 | Ether lipid biosynthetic process | Affects phenotype | PMID:30810372 |
| GO:0009060 | Aerobic respiration | Increases phenotype | PMID:32522588 |
| GO:0010424 | Dna methylation on cytosine within a cg sequence | Affects phenotype | PMID:33872906 |
| GO:0010470 | Regulation of gastrulation | Affects phenotype | PMID:28184906 |
| GO:0010508 | Positive regulation of autophagy | Increases phenotype | PMID:38522500 |
| GO:0010718 | Positive regulation of epithelial to mesenchymal transition | Increases phenotype | PMID:34380243 |
| GO:0010867 | Positive regulation of triglyceride biosynthetic process | Increases phenotype | PMID:31004931; PMID:33091777 |
| GO:0010884 | Positive regulation of lipid storage | Increases phenotype | PMID:25777084 |
| GO:0010917 | Negative regulation of mitochondrial membrane potential | Increases phenotype | PMID:33029813; PMID:33161305; PMID:36005737 |
| GO:0010918 | Positive regulation of mitochondrial membrane potential | Increases phenotype | PMID:37979351 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:26710974; PMID:33161305 |
| GO:0014068 | Positive regulation of phosphatidylinositol 3-kinase signaling | Increases phenotype | PMID:34380243 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:25543134; PMID:28988496; PMID:32522588 |
| GO:0016049 | Cell growth | Decreases phenotype | PMID:29663635; PMID:30810372 |
| GO:0016209 | Antioxidant activity | Decreases phenotype | PMID:32566080; PMID:34141174 |
| GO:0016477 | Cell migration | Increases phenotype | PMID:28390675; PMID:33631300; PMID:34910997 |
| GO:0018963 | Phthalate metabolic process | Increases phenotype | PMID:30078309; PMID:35354077 |
| GO:0019216 | Regulation of lipid metabolic process | Affects phenotype | PMID:38050670 |
| GO:0019249 | Lactate biosynthetic process | Increases phenotype | PMID:25543134 |
| GO:0019369 | Arachidonic acid metabolic process | Affects phenotype | PMID:27384973 |
| GO:0020027 | Hemoglobin metabolic process | Affects phenotype | PMID:32916427 |
| GO:0030154 | Cell differentiation | Decreases phenotype | PMID:30810372 |
| GO:0030335 | Positive regulation of cell migration | Increases phenotype | PMID:22321834; PMID:33027880; PMID:34380243; PMID:35861251 |
| GO:0031324 | Negative regulation of cellular metabolic process | Increases phenotype | PMID:35861251 |
| GO:0031589 | Cell-substrate adhesion | Decreases phenotype | PMID:38563870 |
| GO:0031941 | Filamentous actin | Affects phenotype | PMID:36087924 |
| GO:0032148 | Activation of protein kinase b activity | Decreases phenotype | PMID:31228551 |
| GO:0032205 | Negative regulation of telomere maintenance | Increases phenotype | PMID:36174712 |
| GO:0032310 | Prostaglandin secretion | Affects phenotype | PMID:34942354 |
| GO:0032487 | Regulation of rap protein signal transduction | Increases phenotype | PMID:38522500 |
| GO:0032776 | Dna methylation on cytosine | Decreases phenotype | PMID:29081338 |
| GO:0032930 | Positive regulation of superoxide anion generation | Increases phenotype | PMID:25677926 |
| GO:0033212 | Iron import into cell | Increases phenotype | PMID:36696656; PMID:38050670 |
| GO:0033686 | Positive regulation of luteinizing hormone secretion | Increases phenotype | PMID:31015488 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:24836450; PMID:29259978; PMID:39360521 |
| GO:0034599 | Cellular response to oxidative stress | Increases phenotype | PMID:38503103 |
| GO:0034729 | Histone h3-k79 methylation | Increases phenotype | PMID:37545493; PMID:37611859 |
| GO:0035929 | Steroid hormone secretion | Affects phenotype | PMID:31884101 |
| GO:0035936 | Testosterone secretion | Increases phenotype | PMID:24393508; PMID:24945889; PMID:31884101 |
| GO:0035938 | Estradiol secretion | Increases phenotype | PMID:31884101 |
| GO:0035941 | Androstenedione secretion | Increases phenotype | PMID:31884101 |
| GO:0035942 | Dehydroepiandrosterone secretion | Increases phenotype | PMID:31884101 |
| GO:0036211 | Protein modification process | Affects phenotype | PMID:39360521 |
| GO:0040016 | Embryonic cleavage | Affects phenotype | PMID:28042535 |
| GO:0040029 | Epigenetic regulation of gene expression | Affects phenotype | PMID:33872906 |
| GO:0042307 | Positive regulation of protein import into nucleus | Increases phenotype | PMID:31351048 |
| GO:0042403 | Thyroid hormone metabolic process | Affects phenotype | PMID:27152641 |
| GO:0042448 | Progesterone metabolic process | Affects phenotype | PMID:20463053 |
| GO:0042554 | Superoxide anion generation | Affects phenotype | PMID:34627990 |
| GO:0042593 | Glucose homeostasis | Decreases phenotype | PMID:31228551 |
| GO:0042701 | Progesterone secretion | Increases phenotype | PMID:31884101; PMID:34627990 |
| GO:0042743 | Hydrogen peroxide metabolic process | Affects phenotype | PMID:20453712 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:28238932; PMID:31228551; PMID:31351048; PMID:33029813; PMID:33159713; PMID:33161305; PMID:33162236; PMID:33162236; PMID:37975621; PMID:36889213; PMID:37941498; PMID:37975621; PMID:37979351; PMID:38113427; PMID:38522500 |
| GO:0043280 | Positive regulation of cysteine-type endopeptidase activity involved in apoptotic process | Increases phenotype | PMID:37941498 |
| GO:0043517 | Positive regulation of dna damage response, signal transduction by p53 class mediator | Increases phenotype | PMID:36174712 |
| GO:0043651 | Linoleic acid metabolic process | Affects phenotype | PMID:27384973 |
| GO:0043966 | Histone h3 acetylation | Increases phenotype | PMID:29718165; PMID:37545493 |
| GO:0043967 | Histone h4 acetylation | Increases phenotype | PMID:37545493 |
| GO:0043970 | Histone h3-k9 acetylation | Increases phenotype | PMID:34910997 |
| GO:0043973 | Histone h3-k4 acetylation | Increases phenotype | PMID:37611859 |
| GO:0044237 | Cellular metabolic process | Increases phenotype | PMID:24836450; PMID:33631300; PMID:34910997; PMID:34942354; PMID:35510228; PMID:39307383 |
| GO:0044255 | Cellular lipid metabolic process | Affects phenotype | PMID:34323617 |
| GO:0044319 | Wound healing, spreading of cells | Decreases phenotype | PMID:36087924 |
| GO:0044381 | Glucose import in response to insulin stimulus | Decreases phenotype | PMID:32255176 |
| GO:0045017 | Glycerolipid biosynthetic process | Affects phenotype | PMID:30810372 |
| GO:0045333 | Cellular respiration | Decreases phenotype | PMID:30648648; PMID:34627990 |
| GO:0045444 | Fat cell differentiation | Increases phenotype | PMID:22953781; PMID:28921615 |
| GO:0045454 | Cell redox homeostasis | Decreases phenotype | PMID:36696656 |
| GO:0045600 | Positive regulation of fat cell differentiation | Increases phenotype | PMID:25777084 |
| GO:0045669 | Positive regulation of osteoblast differentiation | Decreases phenotype | PMID:25777084 |
| GO:0045719 | Negative regulation of glycogen biosynthetic process | Increases phenotype | PMID:31228551 |
| GO:0045722 | Positive regulation of gluconeogenesis | Increases phenotype | PMID:31228551 |
| GO:0045778 | Positive regulation of ossification | Decreases phenotype | PMID:25777084 |
| GO:0045880 | Positive regulation of smoothened signaling pathway | Increases phenotype | PMID:26710974 |
| GO:0045992 | Negative regulation of embryonic development | Increases phenotype | PMID:36535558 |
| GO:0046034 | Atp metabolic process | Affects phenotype | PMID:32522588 |
| GO:0046323 | Glucose import | Increases phenotype | PMID:31009676 |
| GO:0046326 | Positive regulation of glucose import | Increases phenotype | PMID:36438553 |
| GO:0046339 | Diacylglycerol metabolic process | Affects phenotype | PMID:35075242 |
| GO:0046474 | Glycerophospholipid biosynthetic process | Affects phenotype | PMID:30810372 |
| GO:0046722 | Lactic acid secretion | Increases phenotype | PMID:31009676 |
| GO:0046879 | Hormone secretion | Affects phenotype | PMID:25810477 |
| GO:0048515 | Spermatid differentiation | Increases phenotype | PMID:34010400 |
| GO:0048599 | Oocyte development | Decreases phenotype | PMID:25810477 |
| GO:0048863 | Stem cell differentiation | Decreases phenotype | PMID:32205227 |
| GO:0050729 | Positive regulation of inflammatory response | Increases phenotype | PMID:31016965; PMID:34010400 |
| GO:0050765 | Negative regulation of phagocytosis | Increases phenotype | PMID:29718165 |
| GO:0050810 | Regulation of steroid biosynthetic process | Affects phenotype | PMID:31015488 |
| GO:0050996 | Positive regulation of lipid catabolic process | Increases phenotype | PMID:35143864; PMID:36696656; PMID:38050670 |
| GO:0051560 | Mitochondrial calcium ion homeostasis | Affects phenotype | PMID:39307383 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Affects phenotype | PMID:24836450; PMID:24836450; PMID:28988496; PMID:28988496; PMID:34627990; PMID:39307383; PMID:39307383 |
| GO:0051882 | Mitochondrial depolarization | Increases phenotype | PMID:24836450 |
| GO:0052697 | Xenobiotic glucuronidation | Decreases phenotype | PMID:27071666 |
| GO:0060014 | Granulosa cell differentiation | Affects phenotype | PMID:39752319 |
| GO:0060326 | Cell chemotaxis | Increases phenotype | PMID:20453712; PMID:33631300 |
| GO:0060706 | Cell differentiation involved in embryonic placenta development | Affects phenotype | PMID:30810372 |
| GO:0061179 | Negative regulation of insulin secretion involved in cellular response to glucose stimulus | Increases phenotype | PMID:34141174; PMID:38048874 |
| GO:0061370 | Testosterone biosynthetic process | Affects phenotype | PMID:20463053 |
| GO:0061519 | Macrophage homeostasis | Affects phenotype | PMID:29743262 |
| GO:0070265 | Necrotic cell death | Increases phenotype | PMID:28042535; PMID:29259978 |
| GO:0070341 | Fat cell proliferation | Increases phenotype | PMID:22953781 |
| GO:0070584 | Mitochondrion morphogenesis | Decreases phenotype | PMID:34863575 |
| GO:0070730 | Camp transport | Affects phenotype | PMID:26985823 |
| GO:0070994 | Detection of oxidative stress | Increases phenotype | PMID:35510228; PMID:37286014 |
| GO:0071888 | Macrophage apoptotic process | Increases phenotype | PMID:29743262 |
| GO:0071901 | Negative regulation of protein serine/threonine kinase activity | Increases phenotype | PMID:31351048 |
| GO:0072520 | Seminiferous tubule development | Decreases phenotype | PMID:30476341; PMID:31015488; PMID:33360214; PMID:36189433 |
| GO:0072593 | Reactive oxygen species metabolic process | Increases phenotype | PMID:20463053; PMID:23077170; PMID:24836450; PMID:28988496; PMID:29259978; PMID:34627990; PMID:34627990; PMID:39307383; PMID:36087924; PMID:39307383; PMID:39360521 |
| GO:0080009 | Mrna methylation | Increases phenotype | PMID:36174712; PMID:36314267 |
| GO:0080182 | Histone h3-k4 trimethylation | Increases phenotype | PMID:37545493; PMID:37611859 |
| GO:0090181 | Regulation of cholesterol metabolic process | Affects phenotype | PMID:37093692 |
| GO:0097198 | Histone h3-k36 trimethylation | Increases phenotype | PMID:37545493; PMID:37611859 |
| GO:0097368 | Establishment of sertoli cell barrier | Decreases phenotype | PMID:36087924; PMID:37941498 |
| GO:0097676 | Histone h3-k36 dimethylation | Decreases phenotype | PMID:29718165 |
| GO:0106395 | Positive regulation of palmitic acid catabolic process | Increases phenotype | PMID:32255176 |
| GO:0110017 | Cap-independent translational initiation of linear mrna | Decreases phenotype | PMID:27992464 |
| GO:0140042 | Lipid droplet formation | Increases phenotype | PMID:22953781; PMID:28921615; PMID:30810372; PMID:31004931 |
| GO:0140639 | Positive regulation of pyroptosis | Increases phenotype | PMID:33159713; PMID:37692514 |
| GO:0140747 | Regulation of ncrna transcription | Affects phenotype | PMID:37003585 |
| GO:0150129 | Positive regulation of interleukin-33 production | Increases phenotype | PMID:37545493 |
| GO:0160020 | Positive regulation of ferroptosis | Increases phenotype | PMID:34863575; PMID:36696656; PMID:38050670 |
| GO:1900017 | Positive regulation of cytokine production involved in inflammatory response | Increases phenotype | PMID:30398665 |
| GO:1900227 | Positive regulation of nlrp3 inflammasome complex assembly | Increases phenotype | PMID:31016965; PMID:33159713 |
| GO:1900409 | Positive regulation of cellular response to oxidative stress | Increases phenotype | PMID:37692514 |
| GO:1900535 | Palmitic acid biosynthetic process | Increases phenotype | PMID:27384973 |
| GO:1900745 | Positive regulation of p38mapk cascade | Increases phenotype | PMID:29940330 |
| GO:1901165 | Positive regulation of trophoblast cell migration | Decreases phenotype | PMID:28416457 |
| GO:1901318 | Negative regulation of flagellated sperm motility | Increases phenotype | PMID:24140385 |
| GO:1901526 | Positive regulation of mitophagy | Increases phenotype | PMID:33161305; PMID:37692514 |
| GO:1901670 | Negative regulation of superoxide dismutase activity | Increases phenotype | PMID:32566080; PMID:33120273 |
| GO:1901671 | Positive regulation of superoxide dismutase activity | Increases phenotype | PMID:32255176 |
| GO:1901740 | Negative regulation of myoblast fusion | Increases phenotype | PMID:32255176 |
| GO:1901858 | Regulation of mitochondrial dna metabolic process | Affects phenotype | PMID:32255176 |
| GO:1902624 | Positive regulation of neutrophil migration | Increases phenotype | PMID:34010400 |
| GO:1902750 | Negative regulation of cell cycle g2/m phase transition | Increases phenotype | PMID:33162236 |
| GO:1902807 | Negative regulation of cell cycle g1/s phase transition | Increases phenotype | PMID:33162236 |
| GO:1902884 | Positive regulation of response to oxidative stress | Increases phenotype | PMID:33120273 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:26597031; PMID:29663635; PMID:30648648 |
| GO:1903427 | Negative regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:31351048 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:29940330; PMID:31016965; PMID:32255176; PMID:33029813; PMID:33120273; PMID:33161305; PMID:33360214; PMID:33360214; PMID:37975621; PMID:34863575; PMID:35143864; PMID:36005737; PMID:36438553; PMID:36696656; PMID:37692514; PMID:37975621; PMID:37979351; PMID:38050670 |
| GO:1903537 | Meiotic cell cycle process involved in oocyte maturation | Affects phenotype | PMID:28042535 |
| GO:1903703 | Enterocyte differentiation | Affects phenotype | PMID:38563870 |
| GO:1903787 | Negative regulation of glutathione biosynthetic process | Increases phenotype | PMID:32566080; PMID:36696656 |
| GO:1904445 | Negative regulation of establishment of sertoli cell barrier | Increases phenotype | PMID:38565259 |
| GO:1905053 | Positive regulation of base-excision repair | Increases phenotype | PMID:33120273 |
| GO:1905517 | Macrophage migration | Increases phenotype | PMID:29743262 |
| GO:1905523 | Positive regulation of macrophage migration | Increases phenotype | PMID:34010400; PMID:38565259 |
| GO:1905898 | Positive regulation of response to endoplasmic reticulum stress | Increases phenotype | PMID:36005737 |
| GO:1990266 | Neutrophil migration | Increases phenotype | PMID:29743262 |
| GO:1990428 | Mirna transport | Affects phenotype | PMID:30481674 |
| GO:1990636 | Reproductive senescence | Increases phenotype | PMID:31015488 |
| GO:2000224 | Regulation of testosterone biosynthetic process | Increases phenotype | PMID:22461451; PMID:25677926 |
| GO:2000225 | Negative regulation of testosterone biosynthetic process | Increases phenotype | PMID:24140385 |
| GO:2000355 | Negative regulation of ovarian follicle development | Increases phenotype | PMID:31015488; PMID:38685446 |
| GO:2000610 | Negative regulation of thyroid hormone generation | Increases phenotype | PMID:36005737; PMID:38042133 |
| GO:2000611 | Positive regulation of thyroid hormone generation | Affects phenotype | PMID:34708313 |
| GO:2000786 | Positive regulation of autophagosome assembly | Increases phenotype | PMID:37692514 |
| GO:2000844 | Negative regulation of testosterone secretion | Increases phenotype | PMID:32566080; PMID:33360214 |
| GO:2000845 | Positive regulation of testosterone secretion | Increases phenotype | PMID:26316063; PMID:31015488; PMID:36189433 |
| GO:2000854 | Positive regulation of corticosterone secretion | Increases phenotype | PMID:37886449 |
| GO:2000866 | Positive regulation of estradiol secretion | Increases phenotype | PMID:31015488; PMID:31771930 |
| GO:2000872 | Positive regulation of progesterone secretion | Increases phenotype | PMID:31771930 |
| GO:2000987 | Positive regulation of behavioral fear response | Increases phenotype | PMID:37886449 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.